认知/记忆增强药物市场：按药物类型、应用分类 - 全球预测 2025-2030

2023年认知与记忆增强药物市值为59.3亿美元，预计到2024年将达到64.9亿美元，复合年增长率为9.57%，到2030年将达到112.5亿美元。

认知和记忆增强药物通常称为精神药物，是一种旨在透过多种机制改善心理表现、针对记忆、注意力、动机和其他执行功能的药物和补充品。工作量的增加和人口老化加剧了对这些药物的需求，年轻的专业人士希望在竞争环境中获得优势，而老年人则寻求减轻与老龄化相关的认知能力下降，这推动了认知增强的需求。最终用途包括医疗保健、治疗阿兹海默症和注意力不足过动症等神经系统疾病，以及提高学术和劳动力表现。市场开拓受到心理健康意识增强、药物配方技术进步、主要企业研发投资增加等因素的影响。机会存在于开发副作用较少的化合物、扩大天然和有机产品线以及瞄准亚洲和拉丁美洲的新兴市场。

然而，关于认知增强剂非医疗用途的严格法律规范和伦理问题构成了重大挑战。与长期使用相关的副作用和潜在的滥用会进一步阻碍生长。最佳创新领域包括开发将药理学进步与数位治疗方法相结合的综合解决方案，透过基因分析探索个人化医疗方法，以及增强递送机制以提高生物有效性。该市场竞争激烈，其特点是快速的技术交流和不断涌入的新兴企业对老牌製药巨头构成挑战。专注于永续和道德开发产品的创新和研究可能会成为进步和接受背后的驱动力。为了利用这些机会，公司应该投资与学术界和行销部门的策略伙伴关係关係，以教育潜在消费者有关促智药的益处和安全性。市场动态发展的本质需要敏捷性和持续适应不断变化的消费者期望和监管环境。

市场动态：揭示快速发展的认知和记忆增强药物市场的关键市场洞察

供需的动态交互作用正在改变认知和记忆增强药物市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

• 市场驱动因素
  • 越来越多的人患有神经退化性疾病
  • 老年人口增加
  • 更多考虑认知和记忆增强药物在学术和体育方面的应用
• 市场限制因素
  • 药物研发成本高
• 市场机会
  • 新药和治疗方法的开发
  • 政府核准开发新药
• 市场挑战
  • 副作用的风险

波特的五种力量策略工具驾驭认知与记忆增强药物市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解认知和记忆增强药物市场的外部影响

外部宏观环境因素在塑造认知和记忆增强药物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解认知/记忆增强剂市场的竞争状况

认知和记忆增强药物市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵认知与记忆增强药物市场供应商的绩效评估

FPNV 定位矩阵是评估认知和记忆增强药物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘认知和记忆增强药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对认知和记忆增强药物市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 越来越多的人患有神经退化性疾病
    • 老年人口增加
    • 更多考虑认知和记忆增强药物在学术和体育方面的应用
  • 抑制因素
    • 药物研发高成本
  • 机会
    • 新药和治疗方法的开发
    • 政府核准开发新药
  • 任务
    • 副作用的风险
• 市场区隔分析
• 波特五力分析
• PESTEL分析
  • 政治的
  • 经济
  • 社群
  • 技术的
  • 合法地
  • 环境

第六章依药物类型分類的认知/记忆增强药物市场

• 阿得拉
• 安理申
• 艾克森
• 纳门达
• 普罗维登斯
• 拉札迪因
• 利他能

第七章认知/记忆增强药物市场：依应用分类

• 学业成绩
• 运动表现
• 疾病治疗

第八章北美和南美认知和记忆增强药物市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太认知与记忆增强药物市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章欧洲、中东和非洲认知与记忆增强药物市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争格局

• 2023 年市场占有率分析
• FPNV 定位矩阵，2023
• 竞争情境分析
• 战略分析和建议

公司名单

• AbbVie Inc.
• Amway Corporation
• Biogen Inc.
• Eisai Co., Ltd.
• Eli Lilly and Company
• Glanbia PLC
• Johnson & Johnson Services, Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceutical Industries Ltd.
• Unilever PLC
• WebMD LLC

The Cognitive & Memory Enhancer Drugs Market was valued at USD 5.93 billion in 2023, expected to reach USD 6.49 billion in 2024, and is projected to grow at a CAGR of 9.57%, to USD 11.25 billion by 2030.

Cognitive and memory enhancer drugs, often referred to as nootropics, are pharmaceuticals and supplements designed to improve mental performance by various mechanisms, targeting memory, attention, motivation, and other executive functions. The necessity for these drugs is underscored by increasing workloads and the aging population, prompting demand for enhanced cognitive function in both young professionals seeking an edge in competitive environments and the elderly aiming to mitigate age-related cognitive decline. End-use applications span across healthcare for treating neurological disorders such as Alzheimer's and ADHD, to use in academia and the workforce for performance enhancement. Market growth is influenced by factors such as rising awareness about mental health, technological advancements in pharmaceutical formulations, and increased investment in research and development by key players. Opportunities exist in developing compounds with fewer side effects, expanding natural and organic product lines, and targeting emerging markets in Asia and Latin America.

However, stringent regulatory frameworks and ethical concerns over the non-medical use of cognitive enhancers pose significant challenges. Side effects associated with long-term usage and the potential for misuse further hinder growth. The best areas for innovation include developing integrative solutions that combine pharmacological advancements with digital therapeutics, exploring personalized medicine approaches through genetic profiling, and enhancing delivery mechanisms for improved bioavailability. The market is competitive, marked by rapid technological exchange and a constant influx of start-ups challenging established pharmaceutical giants. Innovation and research focused on sustainable and ethically developed products will likely drive progress and acceptance. To capitalize on these opportunities, companies should invest in strategic partnerships with academia and invest in marketing to educate potential consumers on the benefits and safety of cognitive enhancers. The dynamic and evolving nature of the market demands agility and continuous adaptation to shifting consumer expectations and regulatory landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cognitive & Memory Enhancer Drugs Market

The Cognitive & Memory Enhancer Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of people suffering from neurodegenerative disorders
  • Rise in geriatric population
  • Increasing consideration of cognitive and memory enhancer drugs for academic and athletic applications
• Market Restraints
  • High cost of drug development
• Market Opportunities
  • Development of novel drugs and therapies
  • Government approval for new drug development
• Market Challenges
  • Risk of side effects

Porter's Five Forces: A Strategic Tool for Navigating the Cognitive & Memory Enhancer Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cognitive & Memory Enhancer Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cognitive & Memory Enhancer Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cognitive & Memory Enhancer Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cognitive & Memory Enhancer Drugs Market

A detailed market share analysis in the Cognitive & Memory Enhancer Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cognitive & Memory Enhancer Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cognitive & Memory Enhancer Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cognitive & Memory Enhancer Drugs Market

A strategic analysis of the Cognitive & Memory Enhancer Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cognitive & Memory Enhancer Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amway Corporation, Biogen Inc., Eisai Co., Ltd., Eli Lilly and Company, Glanbia PLC, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited., Teva Pharmaceutical Industries Ltd., Unilever PLC, and WebMD LLC.

Market Segmentation & Coverage

This research report categorizes the Cognitive & Memory Enhancer Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Type, market is studied across Adderall, Aricept, Exelon, Namenda, Provigil, Razadyne, and Ritalin.
• Based on Application, market is studied across Academic Performance, Athletic Performance, and Disease Treatment.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of people suffering from neurodegenerative disorders
    • 5.1.1.2. Rise in geriatric population
    • 5.1.1.3. Increasing consideration of cognitive and memory enhancer drugs for academic and athletic applications
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of drug development
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of novel drugs and therapies
    • 5.1.3.2. Government approval for new drug development
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of side effects
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cognitive & Memory Enhancer Drugs Market, by Drug Type

• 6.1. Introduction
• 6.2. Adderall
• 6.3. Aricept
• 6.4. Exelon
• 6.5. Namenda
• 6.6. Provigil
• 6.7. Razadyne
• 6.8. Ritalin

7. Cognitive & Memory Enhancer Drugs Market, by Application

• 7.1. Introduction
• 7.2. Academic Performance
• 7.3. Athletic Performance
• 7.4. Disease Treatment

8. Americas Cognitive & Memory Enhancer Drugs Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cognitive & Memory Enhancer Drugs Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cognitive & Memory Enhancer Drugs Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Amway Corporation
• 3. Biogen Inc.
• 4. Eisai Co., Ltd.
• 5. Eli Lilly and Company
• 6. Glanbia PLC
• 7. Johnson & Johnson Services, Inc.
• 8. Novartis AG
• 9. Pfizer Inc.
• 10. Sanofi S.A.
• 11. Takeda Pharmaceutical Company Limited.
• 12. Teva Pharmaceutical Industries Ltd.
• 13. Unilever PLC
• 14. WebMD LLC

LIST OF FIGURES

• FIGURE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COGNITIVE & MEMORY ENHANCER DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ADDERALL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ARICEPT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY EXELON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NAMENDA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PROVIGIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RAZADYNE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RITALIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ACADEMIC PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATHLETIC PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CHINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 41. INDIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 76. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. POLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 84. POLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. QATAR COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 86. QATAR COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 106. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023